In murine kidney IRI models, blockade of Tnfrsf11a worsens injury, whereas recombinant Tnfrsf11 improves kidney function.[77] In type 2 diabetes nephropathy, Chen et al. This evidence concerns the gene TNFRSF11A and type 2 diabetes nephropathy.